Expression of HIV regulatory DNA vaccine constructs

Biogenic Amines

Volumn 15, Issue 1, 1999, Pages 93-112

  Kjerrstrom A ^a   Wahren, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

DNA vaccine; HIV; Regulatory genes

Indexed keywords

AMINO ACID; DNA VACCINE; ENVELOPE PROTEIN; HLA ANTIGEN CLASS 1;

ANTIGEN BINDING; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; NONHUMAN; PLASMID; REGULATOR GENE; REVIEW; VIRUS VIRULENCE;

EID: 0033039785     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Aiken, C., Krause, L., Chen, Y. L., and Trono, D. (1996). Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature sensitive for CD4 downregulation. Virology, 217: 293-300.
2. Albini, A., Ferrini, S., Benelli, R., Sforzini, S., Giunciuglio, D., Grazia-Aluigi, M., Proudfoot, A. E. I., Alouani, S., Wells, T. N. C.; Mariani, G., Rabin, R. L., Farber, J. M., and Noonan, D. (1998) HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA, 95: 13153-13158.
3. Biswas, D. K., Salas, T. R., Wang, F., Ahlers, C. M., Dezube, B. J., and Pardee, A. B. (1995). A Tat-induced auto-up-regulatory Loop for superactivation of the Human Immunodeficiency Virus Type 1 promoter. J. Virol, 69: 7437-7444.
4. Blazevic V., Ranki, A., Mattinen, S., Valle, S. L., Koskimies, S., Jung, G. and Krohn, K. J. (1993). Helper T-cell recognition of HIV-1 Tat synthetic peptides. J. Acquir. Immune Defic. Syndr., 6: 881-890.
5. Bubeck, B., Winkler, M., and Bautsch, W. (1993). Rapid homologous recombination in vivo. Nucleic Acids Res., 21: 3601-3602.
6. Calarota, S., Bratt, G., Nordlund, S., Hinkula, J., Leandersson, A-C., Sandström, E., and Wahren, B. (1998). Cellular cytotoxic response induced by DNA vaccination in HIV-1 infected patients. Lancet, 351: 1320-1325.
7. Choppin J, Martinon F, Connan F, Gomard E, and Levy J-P. (1991). HLA-binding regions of HIV-1 proteins. J Imm., 147: 569-574.
8. Collins, K., Chen, B., Kalams, S., Walker, B., and Baltimore, D. (1998). HIV-1 nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature, 391: 397-401.
9. Deacon, N.J., Tyskin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D.J., McPhee, D.A., Greenway, A.L., Ellet, A., Chatfield, C., Lawson, V.A., Crowe, S., Maerz, A., Sonza, S., Learmont, J., Sullivan, J.S., Cunningham, A., Dwyer, D., Dowton, D. and Mills, J. (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science, 270: 988-991.
10. Feinberg, M.B., and Greene, W.C. (1992). Molecular insights into immunodeficiency virus type 1 pathogenesis. Curr. Opin. Immunol., 4: 466-474.
11. Fritz, C.C., Zapp, M.L., and Green, M.R. (1995). A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature, 376: 530-533.
12. Goldstein, G. (1997). HIV Tat protein as a potential AIDS vaccine. Nat. Med., 78: 1913-1918.
13. Hadida, F., Parrot, A., Kieny, M-P., Sadat-Sowti, B., Mayaud, C., Debre, P. and Autran, B. (1992). Carboxy-terminal and central regions of Human Immunodeficiency virus-1 Nef recognized by cytotoxic T lymphocytes from lymphoid organs . J Clin. Invest., 89: 53-60.
14. Hanna Z, Kay D, Rebai N, Guimond A, Jothy S and Jolicoeur P. (1998). Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell, 95: 163-175.
15. Hinkula, J., Lundholm, P., and Wahren, B. (1997a). Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses. Vaccine, 15: 874-878.
16. Hinkula, J., Svanholm, C., Schwartz, S., Lundholm, P., Brytting, M., Engström, G., Benthin, E., Glaser, H., Sutter, G., Kohleisen, B., Erfle, V., Okuda, K., Wigzell, H. and Wahren, B. (1997b). Recognition of prominent viral epitopes is induced by immunization with human immunodeficiency virus type 1 regulatory genes. J. Virol., 71: 5528-5539.
17. Hua, J., Caffrey, J.J. and Cullen, B.R. (1996). Functional consequences of natural sequence variation in the activation domain of HIV-1 Rev. Virology, 222: 423-429.
18. Huang, L., Bosch, I., Hofmann, W., Sodroski, J. and Pardee, A.B. (1998). Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J. Virol., 72: 8952-8960.
19. Iafrate, A.J., Bronson, S. and Skowronski, J. (1997). Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expresson and CD3 signalling. EMBO J, 16: 673-684.
20. Karlsson, A., Parsmyr, K., Sandström, E., Fenyö, E. M. and Albert, J. (1994). MT-1 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J Clin. Microbiol., 32: 364-370.
21. Lafrenie, R.M., Wahl, L.M., Epstein, J.S., Yamada, K.M. and Dhawan, S. (1997). Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J. Immunol., 159: 4077-4083.
22. Li, C.J., Friedman, D.J., Wang, C., Metelev, V. and Pardee, A.B. (1995). Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science, 268: 429-431.
23. MacGregor, R.R., Boyer, J.D., Ugen, K.E., Lacy, K.E., Gluckman, S.J., Bagarazzi, M.L., Chattergoon, M.A., Baine, Y., Higgins, T.J., Ciccarelli, R.B., Coney, L.R., Ginsberg, R.S. and Weiner, D.B. (1998). First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis., 178: 92-100.
24. Mariani, R., Kirchhoff, F., Greenough, T.C., Sullivan, J.L., Desrosier, R.C. and Skowronski, J. (1996). High frequency of defective nef alleles in a long-term survivor with non-progressive HIV-infection. J Virol., 70: 7752-7764.
25. Mermer, B., Felber, B.K., Campbell, M. and Pavlakis, G.N. (1990). Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res., 18: 2037-2044.
26. Miller, R.H., and Sarver, N. (1997). HIV accessory proteins as therapeutic targets. Nat. Med., 3: 389-394.
27. Montagnier, L. (1995). Nef Vaccination against HIV disease. Lancet, 346: 1170.
28. Montgomery, D.L., Shiver, J.W., Leander, K.R., Perry, H.C., Friedman, A., Martinez, D., Ulmer, J.B., Donelly, J.J. and Liu, M. (1993). A. Heterologous and homologous protection against Influenza A by DNA vaccination: Optimization of DNA vectors. DNA Cell Biol., 12: 777-783.
29. Murphy, R. and Wente, S.R. (1996). An RNA-export mediator with an essential nuclear export signal. Nature, 383: 357-360.
30. Okuda, K., Bukawa, H., Hamajima, K., Kawamoto, S., Sekigawa, K-I., Yamada, Y., Tanaka, S-I., Ishii, N., Aoki, I., Nakamura, M., Yamamoto, H., Cullen, B.R. and Fukushima, J. (1995). Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV Type 1 env and rev gene products. AIDS Res. Hum. Retroviruses, 11: 933-943.
31. Ott, M., Emiliani, S., Van Lint, C., Herbein, G., Lovett, G., Chirmule, N., McCloskey, T., Pahwa, S. and Verdin, E. (1997). Immune hyperactivation of HLV-1-infected T cells mediated by Tat and the CD28 pathway. Science, 275: 1481-1485.
32. Poeschla, E. and Wong-Staal, F. (1994). Molecular biology of HIV: challenges for the second decade. AIDS Res. Hum. Retroviruses, 10: 111-112.
33. Putkonen P, Quesada-Rolander M, Leandersson A-C, Schwartz S, Thorstensson R, Okuda K, Wahren B and Hinkula J. (1998). Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinnant subunit protein boosts. Virology, 250: 293-301.
34. Ranki, A., Lagerstedt, A., Ovod, V., Aavik, E. and Krohn, K. (1994). Expression kinetics and subcellular localization of HIV-1 regulatory proteins nef, tat and rev in acutely and chronically infected lymphoid cells. Arch. Virol., 139: 365-378.
35. Rowland-Jones, S., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F., McAdam, S., Whitby, D., Sabally, S., Gallimore, A. and Corrah, T. (1995). HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian woman. Nat. Med., 1: 59-64.
36. Rowland-Jones, S., Tan, R. and McMichael, A. (1997). Role of cellular immunity in protection against HIV infection. Adv. Immunol., 65: 277-346.
37. Schwartz, O., Marechal, V., LeGall, S., Lemonnier, F. and Heard, J.M. (1996). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med., 217: 293-300.
38. Schwartz, S., Felber, B. and Pavlakis, G. (1991). Expression of human immunodeficiency virus type-1 Vif and Vpr mRNA is Rev-dependent and regulated by splicing. Virology, 183: 677-686.
39. Sundqvist, V., Albert, J., Ohlsson, E., Hinkula, J., Fenyö, E.M. and Wahren, B. (1989). Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J. Med. Virol., 29: 170-175.
40. Tähtinen, M., Gombert, F., Hyytinen, E-R., Jung, G., Ranki, A. and Krohn, K. (1992). Fine specificity of the B-cell epitopes recognized in HLV-1 Nef by human sera. Virology, 187: 156-164.
41. Ulmer, J.B. (1997). Elegantly presented DNA Vaccines. Nat. Biotechnol., 15: 842.
42. Van Baalen, C.A., Pontesilli, O.P., Huisman, R.C., Geretti, A.M., Klein, M.R., deWolf, F., Miedema, P., Gruters, R.A. and Osterhaus, A.D.M.E. (1997). Human Immunodeficiency Virus type 1 Rev-and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J. Gen. Virol., 78: 1913-1918.
43. Wahren, B., and Brytting, M. (1997). DNA increases the potency of vaccination against infectious diseases. Curr. Opin. Chem. Biol., 1: 183-189.
44. Wahren, B., Brytting, M.M., Engström, G., Hinkula, J., Levi, M., Ståhle, E.L., Ohlsson, S., Ruden, U. and Schwartz, S. (1996). Immune responses to the HIV rev regulatory gene. Antibiot. Chemother., 48: 105-112.
45. Wang, R., Doolan, D.L., Le, T.P., Hedstrom, R.C., Coonan, K.M., Charoenvit, Y., Jones, T.R., Hobart, P., Margalith, M., Ng, J., Weiss, W.R., Sedegah, M., de Taisne, C., Norman, J. A., and Hoffman, S.L. (1998). Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science; 282: 476-480.